Nicotine Pharmacokinetic and Pharmacodynamics Profile, Safety and Tolerability of P3L
Clinical trial NCT02532374 · COMPLETED
Trial details
- NCT number
- NCT02532374
- Sponsor
- Philip Morris Products S.A.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2015-10-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.